drugset / Trial / NCT00098969

UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants

NCT00098969

Phase 1 Completed 40 enrolled National Cancer Institute (NCI)
Open-labelPrevention

Summary

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of resveratrol may prevent cancer. PURPOSE: This phase I trial is studying the side effects and best dose of resveratrol in preventing cancer in healthy participants.

Timeline

Start
2004-09
Primary completion
Completion

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Resveratrol Small molecule Oral